Correction of high myopic astigmatism

Article

Results of surgical iLASIK procedure indicate better predictability

Wavefront guided ablations with Advanced CustomVue (Abbott Medical Optics, Santa Ana, California, USA) have been proven to be a very effective and safe way to correct myopia and myopic astigmatism.3 Among other technological features, the aforementioned procedure incorporates Iris Registration (IR), which is responsible for compensating any degree of ciclotorsion and pupil centroid shift that happens when the patient lies down under the laser and pupil changes size respectively. No study has been published yet addressing the outcome of this technology in patients with a high degree of astigmatism undergoing femtoLASIK surgery.

We designed a prospective open label comparative study with the objective of evaluating the efficacy, safety and predictability of the iLASIK procedure that combines the Advanced CustomVue procedure and Intralase FS60 (Abbott Medical Optics), in high myopic astigmatism and compare it with the standard femtoLASIK with the VISX S4 (Abbott Medical Optics). The main inclusion criteria was to have a compound myopic astigmatism with a cylinder ranging from 2 up to 5 D and sphere up to –6 D.4

Patients were followed up for a period of 3 months after surgery, including the following measurements uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), predictability, efficacy and safety. Refractive error and visual acuity were treated as continuous variables and analysed for significance by independent t test.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.